Skip to main content
Screener/Healthcare/Biotechnology

ADCT ADC Therapeutics S.A.

NYSE
$3.82+0.04 (+1.06%)
$1.23
$4.98
$3.72
$3.85
EPS (TTM)$-1.20
P/E Ratio-3.97
Dividend Yield
Market Cap$501.1M
Volume644K
Prev Close$3.78
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q4 '25$23.1M-$6.4M$-0.0484.5%-27.8%
Q3 '25$16.4M-$41.0M$-0.3092.7%-249.4%
Q2 '25$18.8M-$56.6M$-0.5095.6%-300.7%
Q1 '25$23.0M-$38.6M$-0.3691.1%-167.6%
Q4 '24$16.9M-$30.7M$-0.2991.9%-181.7%
Q3 '24$18.5M-$44.0M$-0.4295.4%-238.1%
Q2 '24$17.4M-$36.5M$-0.3893.0%-209.9%
Q1 '24$18.1M-$46.6M$-0.5686.1%-258.2%
Get Your Daily Market Recap